Luigi Bertoli is a Hematology physician affiliated with University of Alabama at Birmingham. OpenAlex indexes 63 publications with 1,589 citations (h-index 21).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2022 Brookwood Medical Ctr Dr
Suite G105
Birmingham, AL 352096808
Telephone
205-877-2888Registry record last updated 8 Jul 2007.
Industry payments
37 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Janssen Biotech, Inc.Program year20256 payments
- PFIZER INC.Program year20256 payments
- Octapharma USA, Inc.Program year20256 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
92.1%Human Immunoglobulin G91.8%Immune globulin100%Part B, office-administered≥102 patientsMacrolide Antimicrobial0.1%Azithromycin100%Part D≥24 patients+ 6 more classes in this area
Sensory organs
4.4%Corticosteroid4.4%Dexamethasone sodium phosphate100%Dexamethasone1%Part D + Part B<11 patientsMetabolism & gastrointestinal
1.6%Serotonin-3 Receptor Antagonist1.6%Ondansetron hydrochloride94%Ondansetron Hcl4%Ondansetron Odt2%Part D + Part B<11 patientsCorticosteroid0%Prednisone100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
3 NIH research awards on record, funded 1985–1989 per NIH RePORTER. The latest:
- STUDIES ON THE DEVELOPMENT OF HUMAN B CELL LYMPHOMAS
University of Alabama at Birmingham
FY1987K08CA001005 - STUDIES ON THE DEVELOPMENT OF HUMAN B CELL LYMPHOMAS
University of Alabama at Birmingham
FY1986K08CA001005
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- HLA-A and -B Type and Haplotype Frequencies in IgG Subclass Deficiency Subgroups
Archivum Immunologiae et Therapiae Experimentalis
2020
Similar KOLs
Other experts from the same institution or the same specialty.
Vera Bittner
University of Alabama at Birmingham
Richard Whitley, MD
University of Alabama at Birmingham
David Standaert, MD, PhD
University of Alabama at Birmingham
Erik Roberson
University of Alabama at Birmingham
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”